T-TAS® WS Method Comparison
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Hikari Dx, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?This study involves the collection of blood samples and measurement with the T-TAS PL assay to compare the performance of the T-TAS wS instrument to the T-TAS 01 instrument
Eligibility Criteria
Treatment Details
4Treatment groups
Experimental Treatment
Group I: Von Willebrand DiseaseExperimental Treatment1 Intervention
Subjects with a prior diagnosis of Von Willebrand Disease
Group II: Healthy donorsExperimental Treatment1 Intervention
Subjects with no evidence of primary hemostasis abnormalities
Group III: Dual antiplatelet therapyExperimental Treatment1 Intervention
Subjects taking dual antiplatelet therapy (aspirin plus either clopidogrel, prasugrel, or ticagrelor)
Group IV: Aspirin monotherapyExperimental Treatment1 Intervention
Subjects taking aspirin monotherapy
Find a clinic near you
Research locations nearbySelect from list below to view details:
Sinai Hospital of BaltimoreBaltimore, MD
Loading ...
Who is running the clinical trial?
Hikari Dx, Inc.Lead Sponsor
ZACROS CorporationCollaborator